Charles Ferté

Suggest Changes
Learn More
BACKGROUND Response Evaluation Criteria in Solid Tumors (RECIST) criteria may not be sufficient to evaluate the response of targeted therapies in metastatic renal cell carcinoma (mRCC). The tumor(More)